Topical heparin for recurrent genital herpes simplex virus infections. A proposed model for subsequent therapeutic trials.
A randomized, prospective, placebo-controlled, double-blind study was done of topical heparin for recurrent genital herpes simplex virus (HSV) infections. Our experience can serve as a model for those interested in studying their own approaches to the outpatient treatment of genital HSV in virtually any clinical setting, from standard test dose clinic to private practice.
D000287:Administration, Topical; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D011446:Prospective Studies; D011897:Random Allocation
D006493:Heparin